-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Coya Therapeutics, Maintains $15 Price Target

Benzinga·01/21/2026 12:43:02
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $15 price target.